What did DaVita, Inc. pay for Mount Sinai Hospital Medical Center Renal Unit?

$4.3M. Target revenue was approximately $3.4M.

ACQUIRED · 2022

Who Acquired Mount Sinai Hospital Medical Center Renal Unit?

DaVita, Inc. · $4.3M · 2022

The acquisition

Mount Sinai Hospital Medical Center Renal Unit was acquired by DaVita, Inc. in 2022 for $4.3M.

Mount Sinai Hospital Medical Center Renal Unit at time of acquisition

Revenue

$3.4M

Deal value

$4.3M

Own a medical practice specialty business? See what it's worth.

DaVita, Inc. acquired Mount Sinai Hospital Medical Center Renal Unit for $4.3M. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.

✓Sellability score with 5-driver breakdown and lift estimates
✓Named comparable M&A transactions in your sub-vertical
✓AI-written analysis grounded in your specific inputs

Run my valuation analysis →

Other acquisitions by DaVita, Inc.

Recent transactions by the same buyer — context on their deal flow and footprint.

Manteno Dialysis Centre · 2018 · $2.4M
Presence Saint Mary's Hospital Dialysis · 2018 · $7.3M
Satellite Dialysis of Glenview · 2018 · $2.6M
Renal Ventures Management · 2017 · $359.9M

Similar medical practice specialty acquisitions

Consulting Cardiologists · acquired by Hartford HealthCare in 2026 · $3.0M
EyeSouth Partners' Retina Business · acquired by Cencora, Inc. in 2026 · $1.10B
OneOncology · acquired by Cencora, Inc. in 2025 · $7.40B
OrthoAlliance · acquired by Optum / SCA Health in 2025 · $1.40B
OrthoNY · acquired by Zenyth Partners / Evolve Orthopedic Partners in 2025 · $110.0M